» Articles » PMID: 31285770

LncRNA AY Promotes Hepatocellular Carcinoma Metastasis by Stimulating Transcription

Overview
Journal Theranostics
Date 2019 Jul 10
PMID 31285770
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

: Tumor metastasis is the main cause for cancer-related death. However, the driving molecules of metastasis remain largely unknown. Here, we aim to identify long non-coding RNAs (lncRNAs) critical for human hepatocellular carcinoma (HCC) metastasis. : Microarrays were used to screen a comprehensive set of lncRNAs with differential expression profiles in sulfatide-treated cells. Mass spectrometry, protein arrays, and RNA pull-down experiments were used to identify proteins that interacted with lncRNA. Epigenetic analysis was used to study lncRNA-mediated regulation mechanisms. : We identified lncRNA AY927503 (AY) as a metastasis-associated molecule that was highly expressed in human hepatocellular carcinoma (HCC) and correlated with metastatic events and poor prognosis in patients with HCC. AY promoted HCC cell migration, stemness, 5-fluorouracil resistance, and metastasis in mice. However, knockdown of integrin αV (ITGAV) abolished AY-stimulated migration, cell viability in HCC cells or tube formation. AY strongly promoted transcription and αVβ3 expression by interacting with the promoter specifically and stimulating its activity. AY was identified to interact with histone 1FX (H1FX), but deletion of the central domain of AY (AY∆371-522) abolished H1FX binding and promoter stimulation. AY significantly enriched H3K4Me3 and acH3K9/14 but reduced H3K27Me3 and H1FX occupancy on the promoter, which remodeled chromatin structures for RNA polymerase II recruitment. Knockdown of H1FX abrogated transcription stimulated by AY. : Our findings suggested that lncRNA AY promoted HCC metastasis via induction of chromatin modification for transcription as a pioneer factor and was a potential molecular signature for metastasis or poor prognosis in patients with HCC.

Citing Articles

Comprehensive Multi-Omics Analysis Reveals NPC2 and ITGAV Genes as Potential Prognostic Biomarkers in Gastrointestinal Cancers.

Piroozkhah M, Zabihi M, Jalali P, Salehi Z Cancer Rep (Hoboken). 2024; 7(12):e70087.

PMID: 39690926 PMC: 11652787. DOI: 10.1002/cnr2.70087.


Integrating molecular, biochemical, and immunohistochemical features as predictors of hepatocellular carcinoma drug response using machine-learning algorithms.

Matboli M, Al-Amodi H, Khaled A, Khaled R, Ali M, Kamel H Front Mol Biosci. 2024; 11:1430794.

PMID: 39479501 PMC: 11521808. DOI: 10.3389/fmolb.2024.1430794.


Integrative transcriptome analysis identifies a crotonylation gene signature for predicting prognosis and drug sensitivity in hepatocellular carcinoma.

Yang B, Wen F, Cui Y J Cell Mol Med. 2024; 28(20):e70083.

PMID: 39428564 PMC: 11491312. DOI: 10.1111/jcmm.70083.


Bee Pollen Extract Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells via Ferroptosis-, Wnt-, and Focal Adhesion-Signaling Pathways.

Li Z, Yang J, Sun Y, Han S, Gong J, Zhang Y Drug Des Devel Ther. 2024; 18:2745-2760.

PMID: 38974120 PMC: 11227337. DOI: 10.2147/DDDT.S461581.


The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.

Li R, Zhu C, Wang Y, Wang X, Wang Y, Wang J Cell Death Dis. 2024; 15(4):275.

PMID: 38632251 PMC: 11024199. DOI: 10.1038/s41419-024-06664-z.


References
1.
Felding-Habermann B, Fransvea E, OToole T, Manzuk L, Faha B, Hensler M . Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells. Clin Exp Metastasis. 2002; 19(5):427-36. DOI: 10.1023/a:1016377114119. View

2.
Wu X, Honke K, Zhang Y, Zha X, Taniguchi N . Lactosylsulfatide expression in hepatocellular carcinoma cells enhances cell adhesion to vitronectin and intrahepatic metastasis in nude mice. Int J Cancer. 2004; 110(4):504-10. DOI: 10.1002/ijc.20127. View

3.
Kim K, Choi J, Heo K, Kim H, Levens D, Kohno K . Isolation and characterization of a novel H1.2 complex that acts as a repressor of p53-mediated transcription. J Biol Chem. 2008; 283(14):9113-26. PMC: 2431041. DOI: 10.1074/jbc.M708205200. View

4.
McCarty J . Alphav integrins lead the way for colorectal metastases. Clin Cancer Res. 2008; 14(20):6351-3. PMC: 2688736. DOI: 10.1158/1078-0432.CCR-08-1847. View

5.
Desgrosellier J, Barnes L, Shields D, Huang M, Lau S, Prevost N . An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat Med. 2009; 15(10):1163-9. PMC: 2759406. DOI: 10.1038/nm.2009. View